Skip to content

Clinical trials

Completed Bronchiolitis Obliterans Syndrome trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bronchiolitis Obliterans Syndrome Status: Completed Country / region: United States Clear all

165 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20035
20045
20054
200610
20078
20089
20096
201013
20119
201210
20138
20149
201515
20168
201711
20188
20191
20205
20215
20223
20234
20244
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed165

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Dana-Farber Cancer Institute5
Gilead Sciences5
National Cancer Institute (NCI)5
Pharmacyclics LLC.5
Fred Hutchinson Cancer Center4
Novartis Pharmaceuticals4
Pfizer4
M.D. Anderson Cancer Center3
National Institute of Allergy and Infectious Diseases (NIAID)3
Northwestern University3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bronchiolitis Obliterans Syndrome165
Graft vs Host Disease17
Leukemia13
Pain11
Low Back Pain9
Hepatitis C8
Leukemia, Lymphocytic, Chronic, B-Cell8
Lymphoma, Follicular7
Recurrence7
Stroke7

Trials

Showing 1 to 25 of 165. Each trial links to its page on Pharma Observatory.

65 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.